BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 114720
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.114720
Table 1 Baseline characteristics of the study cohort, mean ± SD/n (%)
Variable
PAS (n = 31)
NPAS (n = 49)
χ2/t
P value
Sex0.0240.877
    Male17 (54.84)26 (53.06)
    Female14 (45.16)23 (46.94)
Ages (olds)56.73 ± 8.1257.80 ± 8.090.5760.567
BMI (kg/m2)23.45 ± 2.1022.70 ± 1.891.6560.102
Smoking history17 (54.84)19 (38.78)1.6140.204
Alcohol consumption9 (29.03)13 (26.53)0.0600.807
Comorbidities
    Arterial hypertension18 (58.07)16 (32.65)5.0170.025
    Type 2 diabetes mellitus10 (32.26)8 (16.33)2.7640.096
    Hyperlipidemia12 (38.71)7 (14.29)6.2550.012
    Anticoagulant/antiplatelet therapy15 (48.39)9 (18.37)8.1480.004
Table 2 Comparison of polyposis lesions and surgical-related indicators between two patient groups, mean ± SD/n (%)
Variable
PAS (n = 31)
NPAS (n = 49)
χ2/t
P value
Polyp location0.1920.661
    Left colon18 (58.07)26 (53.06)
    Right colon13 (41.93)23 (46.94)
Polyp size (mm)16.45 ± 4.9813.20 ± 4.672.9560.004
Number of polyps1.87 ± 0.721.52 ± 0.392.8180.006
Polyp morphology0.2980.585
    Pedunculated12 (38.71)22 (44.90)
    Sessile19 (61.29)27 (55.10)
Resection modality6.1400.013
    EMR15 (48.39)37 (75.51)
    ESD16 (51.61)12 (24.49)
Procedure duration (minutes)45.29 ± 11.1333.70 ± 10.574.6810.000
Prophylactic clip deployment25 (80.65)22 (44.90)10.0100.002
Table 3 Comparison of postoperative recovery indicators between two patient groups, mean ± SD
Variable
PAS (n = 31)
NPAS (n = 49)
t
P value
Length of stay (days)8.19 ± 2.165.76 ± 1.785.4720.000
Time to resumption of oral intake (days)4.06 ± 1.352.69 ± 0.935.3760.000
Time to mobilization (days)5.38 ± 1.723.89 ± 1.354.3190.000
Post-operative VAS score5.24 ± 1.283.27 ± 1.067.4670.000
Table 4 Comparison of postoperative complication rates between the two patient groups, n (%)
Groups
n
Hemorrhage
Perforation
Pyrexia
Infection
Abdominal pain
Complications
PAS316 (19.35)4 (12.90)3 (9.68)4 (12.90)8 (35.48)25 (80.65)
NPAS495 (10.20)2 (4.08)4 (8.16)3 (6.12)8 (16.33)22 (44.90)
χ210.010
P value0.002
Table 5 Multivariate logistic regression analysis of postoperative complications following endoscopic polypectomy
Variable
β
SE
Wald χ2
P value
OR
95%CI
Hypertension1.0490.4754.8880.0272.8561.126-7.240
Hyperlipidemia1.3320.5505.8650.0153.7901.289-11.139
Anticoagulant/antiplatelet therapy1.4270.5157.6780.0064.1671.518-11.434
Prior abdominal surgery1.4370.5177.7330.0054.2081.528-11.585
Polyp size0.1450.0537.3160.0061.1561.041-1.283
Polyp number1.0300.4255.8670.0152.8011.217-6.447
Resection modality1.1910.4895.9180.0153.2891.260-8.583
Procedure duration0.1040.02813.8960.0001.1101.051-1.172
Prophylactic clip deployment1.6320.5389.2100.0025.1141.782-14.671
Table 6 Assessment of the value of various factors in predicting postoperative complications in patients undergoing endoscopic polypectomy
Variable
AUC
95%CI
Sensitivity (%)
Specificity (%)
Maximum Youden index
Hypertension0.6270.500-0.75473.5390.000.635
Hyperlipidemia0.6220.492-0.75270.5980.000.506
Anticoagulant/antiplatelet therapy0.6500.522-0.77867.6595.360.630
Prior abdominal surgery0.6630.541-0.78477.4255.100.325
Polyp size0.6700.547-0.79241.9485.710.277
Polyp number0.6330.506-0.75970.9148.980.200
Resection modality0.6360.508-0.76351.6175.510.271
Procedure duration0.7770.671-0.88367.7483.670.514
Prophylactic clip deployment0.6790.560-0.79880.6555.100.358